4D Molecular Therapeutics (FDMT) Non-Current Deffered Revenue (2019 - 2026)
4D Molecular Therapeutics (FDMT) recorded Non-Current Deffered Revenue of $2.96 million in Q2 2026, compared with $219,000 a year earlier and up 39.1% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Non-Current Deffered Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025, 4D Molecular Therapeutics reported Non-Current Deffered Revenue of $745,000, down 29.5% from FY2024.
- Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of -43.7% (FY2020 to FY2025).
- Across earlier years, Non-Current Deffered Revenue came in at $1.06 million in FY2024 (+8.7%), $972,000 in FY2023 (-9.7%), $1.08 million in FY2022 (-56.8%) and $2.49 million in FY2021 (-81.2%).
- The Q2 2026 figure is the highest quarterly Non-Current Deffered Revenue since Q3 2021.
- On a year-over-year basis, Non-Current Deffered Revenue rose in three of the last seven quarters, with growth averaging 28.6%.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 389.6% in Q1 2026, against a decline of 84.9% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.13 million (Q1 2026), $745,000 (Q4 2025) and $835,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.86 Bn | 1,139.45 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 639.81 Bn | 558.34 Bn | 17.26 Bn | - |
| 3 | AbbVie | 501.68 Bn | 474.79 Bn | 12.70 Bn | - |
| 4 | Merck | 374.79 Bn | 329.16 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.69 Bn | 266.68 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.27 Bn | 241.96 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.38 Bn | 167.58 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.45 Bn | 119.10 Bn | 10.94 Bn | - |
| 10 | 4D Molecular Therapeutics | 875.59 Mn | -584.35 Mn | - | 2.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 Mn |
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 745,000.00 |
| Sep 30, 2025 | 835,000.00 |
| Jun 30, 2025 | 219,000.00 |
| Mar 31, 2025 | 434,000.00 |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 972,000.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 847,000.00 |
| Mar 31, 2023 | 884,000.00 |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.76 Mn |
| Dec 31, 2021 | 2.49 Mn |
| Sep 30, 2021 | 3.01 Mn |
API Access
4D Molecular Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();